Carrier
BCBS Federal Employee Program
The one carrier here whose document actually describes you — and it says the anti-obesity benefit exists.
Every other carrier page on this site ends the same way: the documents are real, and none of them tells you whether they describe your plan. The federal employee program is the exception, and that is why it is worth its own page.
Federal employees and retirees choose a named option at Open Season, and each option publishes a brochure that says on its face that it is the official statement of benefits. There is one for Standard and Basic Option together and another for FEP Blue Focus, each with its own enrollment codes. If you know which option you enrolled in, you know which document governs you — a sentence that cannot honestly be written about any of the other four carriers here.
On this subject the brochure does something else unusual. Where the commercial carriers say weight-loss drugs are excluded under many plans, this one states affirmatively that benefits are available for anti-obesity medications, and points you at the prescription drug section. The benefit question that dominates the other pages is settled here, in writing.
What the brochure does not do is name the drugs. It does not list Wegovy, Zepbound, Saxenda or Foundayo anywhere, and it says the prior-approval list changes during the year. So the certainty runs out exactly where the drug list begins, and this page says where that line falls rather than implying the brochure answers more than it does.
Why this document is different from a coverage policy
A commercial carrier's coverage policy is a national document describing how it would review a request if the benefit existed. This brochure is the benefit. It carries enrollment codes, it names the administrative office, and it states that it is the official statement of benefits.
That changes what you can do with it. On the other pages here the honest advice is to read your own plan document, because the carrier's public policy may not describe you. Here the brochure is your plan document, provided you match it to the option you actually enrolled in.
Two options, two brochures. Standard and Basic share one; FEP Blue Focus has its own with different enrollment codes. Reading the wrong one is the main way to get a confident wrong answer about this plan.
The sentence that settles the benefit question
In the preventive care section, after the obesity counseling benefits, the brochure carries a one-line note: benefits are available for anti-obesity medications, see the prescription drug section. It appears in both brochures.
That is a small sentence doing large work. It means a denial on this plan is unlikely to be a benefit-exclusion denial of the kind that dominates the commercial carriers, because the benefit is stated to exist. A denial is much more likely to be about the specific drug, the prior-approval criteria, or the tier.
The brochure draws the exclusion boundary elsewhere and draws it around things that are not drugs: supplies for weight loss are not covered, and neither are services or supplies for treating obesity or weight reduction that are not specifically listed, which it illustrates with specialized foods, exercise equipment and weight-loss apps.
Where the certainty runs out
We searched both 2026 brochures end to end. Neither one names Wegovy, Zepbound, Saxenda, Foundayo, semaglutide or tirzepatide — not once, across roughly a million characters between them, in a document that mentions obesity dozens of times and prior approval hundreds of times.
That is not an oversight; it is how these documents work. The brochure establishes the benefit and the cost-sharing structure, and the drug-level decisions live in the prior-approval list and the formulary, which the brochure says are updated during the year.
So the practical split for a reader on this plan is: the brochure answers whether the benefit exists and what you would pay at each tier, and it does not answer whether your particular drug is on the list this month. Those are two different questions and only the first one is settled by the contract.
The non-drug program, and who qualifies
The plan also runs a weight management program, and unlike most carrier wellness offerings the brochure states its eligibility rule. Members and dependents aged 13 and older with a qualifying BMI can take part, and participants are sent a cellular-enabled scale.
The brochure describes the program as including personalized health coaching, provider access, medication management and on-demand support, with round-the-clock member support.
It is worth knowing this exists before a conversation about drugs, because the brochure presents the two as parts of the same benefit rather than as alternatives.
Every claim above, with the document behind it
These are the policies we opened and the month we opened them. Each one carries its own policy number and effective date on its face, and those are printed here as the document shows them.
The brochure is the contract, and it says so: "This brochure is the official statement of benefits." It carries the plan's enrollment codes on its face — "104 Standard Option - Self Only 106 Standard Option - Self Plus One 105 Standard Option - Self and Family" and the Basic Option codes alongside them — and the document number RI 71-005. That is why this is the one carrier page here where matching the document to the reader is possible.
Blue Cross and Blue Shield Service Benefit Plan, 2026 Standard and Basic Option brochure (RI 71-005), effective 2026 · source
The benefit is stated to exist, which is the opposite of what the commercial carriers publish. In the preventive care section the brochure notes: "Benefits are available for anti-obesity medications. See Section 5(f)." The same note appears in the FEP Blue Focus brochure.
Blue Cross and Blue Shield Service Benefit Plan, 2026 Standard and Basic Option brochure (RI 71-005), effective 2026 · source
There is a second brochure for a different option, with its own enrollment codes, and it says the same thing about the benefit. FEP Blue Focus publishes separately as RI 71-017 with codes "131 FEP Blue Focus - Self Only 133 FEP Blue Focus - Self Plus One 132 FEP Blue Focus - Self and Family", and it carries both "This brochure is the official statement of benefits" and "Benefits are available for anti-obesity medications." Which document governs you depends on which option you enrolled in.
Blue Cross and Blue Shield Service Benefit Plan, 2026 FEP Blue Focus brochure (RI 71-017), effective 2026 · source
The exclusions are drawn around things that are not prescription drugs. The brochure lists "Supplies for weight loss" among medications and supplies that are not covered, and separately excludes "Services or supplies for the treatment of obesity, weight reduction, or dietary control, that are not specifically listed as covered, such as but not limited to: specialized foods for weight loss, exercise equipment, or mobile weight loss apps."
Blue Cross and Blue Shield Service Benefit Plan, 2026 Standard and Basic Option brochure (RI 71-005), effective 2026 · source
Neither brochure names a single one of these drugs, and we checked rather than assuming. Searching both 2026 brochures — about 579,000 and 452,000 characters of text — returns zero occurrences of Wegovy, Zepbound, Saxenda, Foundayo, semaglutide and tirzepatide. In the same searches "obesity" appears 22 and 27 times and "prior approval" 149 and 143 times, so the search was working. The brochure adds that "updates to the list of drugs and supplies requiring prior approval are made periodically during the year."
Blue Cross and Blue Shield Service Benefit Plan, 2026 Standard and Basic Option and FEP Blue Focus brochures, effective 2026 · source
The plan's published prior-approval fact sheet is about procedures rather than these drugs, which is another way of showing where the drug rules are not. Across its text "prior approval" appears 81 times and obesity appears only as surgery — "Procedures to treat severe obesity" and "Surgery for severe obesity" — while Wegovy, Zepbound, Saxenda, Foundayo and semaglutide appear zero times.
Blue Cross and Blue Shield Service Benefit Plan, 2026 Prior Authorization Fact Sheet, effective 2026 · source
The plan runs a weight management program and publishes who qualifies: "All members and dependents aged 13 and older with a qualifying BMI are eligible for participation." The brochure says participants "will receive a complimentary cellular-enabled weight scale" and that the program "includes personalized health coaching, provider access, medication management, and on-demand support." It does not state what BMI qualifies.
Blue Cross and Blue Shield Service Benefit Plan, 2026 Standard and Basic Option brochure (RI 71-005), effective 2026 · source
What these documents cannot tell you
Unusually for this site, the document above IS your plan document if you are enrolled in the option it names. These are the things it still does not settle.
- This page is about one plan for federal employees, retirees and their families. If you are not enrolled in the Service Benefit Plan through the FEHB or PSHB programs, none of it describes your coverage — the commercial Blue plans are separate companies with separate rules.
- Match the brochure to your option before relying on anything here. Standard and Basic share one document and FEP Blue Focus has another, with different enrollment codes and different cost sharing.
- The brochure settles that an anti-obesity drug benefit exists. It does not settle whether your specific drug is covered this month: it names none of them, and it says the prior-approval list is updated during the year.
- Brochures are annual. The ones read here are the 2026 editions, and a new one is published for each plan year.
- None of this is legal or medical advice, and this page does not predict how an appeal will come out. Your brochure and the notice you received govern your case.
Where this comes from
- Blue Cross and Blue Shield Service Benefit Plan, 2026 Standard and Basic Option brochure (RI 71-005), effective 2026 — www.fepblue.org/-/media/PDFs/Brochures/Standard-and-Basic-brochure-2026.
- Blue Cross and Blue Shield Service Benefit Plan, 2026 FEP Blue Focus brochure (RI 71-017), effective 2026 — www.fepblue.org/-/media/PDFs/Brochures/FEP-Blue-Focus-brochure-2026.pdf
- Blue Cross and Blue Shield Service Benefit Plan, 2026 Prior Authorization Fact Sheet, effective 2026 — www.fepblue.org/-/media/PDFs/Brochures/2026/Prior-Authorization-Fact-She
Where to go next
- Cigna: three BMI thresholds, and a benefit above them
- Aetna: where its own criteria stop applying
- Anthem: the answer has a shelf life
- How employer and commercial plans treat GLP-1s
- How to appeal a commercial or employer plan denial
- Every carrier we have read
American GLP is not a law firm, an insurer, a government office or a clinician, and nothing here is legal or medical advice. This page describes what BCBS Federal Employee Program publishes. It is not affiliated with Blue Cross Blue Shield Association, and your own plan documents and your own notice govern your case. Policies carry effective dates and change — read the sources before you act.